Bharat Biotech will sell its Covaxin vaccine against the coronavirus to state governments at Rs 600 per dose and private hospitals at Rs 1200 per dose. In a statement, Bharat Biotech chairman and managing director Krishna Ella said the company is supplying the vaccine to the central government at Rs 150 per dosage and the government on its part is distributing it free of cost.
Announcing the prices, Bharat Biotech on Saturday said Covaxin will be also be exported and the export price would be between $15-20 (Rs 1,123 to Rs 1,498 approximately).
The announcement comes days after the Serum Institute of India announced price of its Covishield vaccine. At present, apart from Bharat Biotech’s Covaxin, Covishield is the only other Covid-19 vaccine which is being used in India’s vaccination drive.
The Serum Institute has fixed Covishiled’s price at Rs 400 for state governments and Rs 600 for private hospitals.
In a statement, Bharat Biotech said it is “deeply concerned” by the ongoing Covid-19 pandemic in India and rest of the world.
“Bharat Biotech is honoured to develop, manufacture and supply Covaxin for India’s vaccine rollout at Rs 150 per dose, which is distributed for free by the Government of India. We would like to state that more than 50 per cent of our capacities have been reserved for central government supplies,” the statement said.
Justifying the high price for its Covaxin, Bharat Biotech said it is an “inactivated and highly purified vaccine” and its manufacturing was expensive due to “very low process yields”.
“All costs towards product development, manufacturing facilities and clinical trials were deployed primarily using internal funding and resources of Bharat Biotech,” the statement added.